1. Home
  2. HUT vs ZLAB Comparison

HUT vs ZLAB Comparison

Compare HUT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUT
  • ZLAB
  • Stock Information
  • Founded
  • HUT 2011
  • ZLAB 2013
  • Country
  • HUT United States
  • ZLAB China
  • Employees
  • HUT N/A
  • ZLAB N/A
  • Industry
  • HUT Finance: Consumer Services
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUT Finance
  • ZLAB Health Care
  • Exchange
  • HUT Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • HUT 3.9B
  • ZLAB 3.6B
  • IPO Year
  • HUT N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • HUT $44.40
  • ZLAB $33.69
  • Analyst Decision
  • HUT Strong Buy
  • ZLAB Buy
  • Analyst Count
  • HUT 14
  • ZLAB 6
  • Target Price
  • HUT $31.21
  • ZLAB $57.22
  • AVG Volume (30 Days)
  • HUT 6.5M
  • ZLAB 647.2K
  • Earning Date
  • HUT 11-12-2025
  • ZLAB 11-11-2025
  • Dividend Yield
  • HUT N/A
  • ZLAB N/A
  • EPS Growth
  • HUT N/A
  • ZLAB N/A
  • EPS
  • HUT 1.48
  • ZLAB N/A
  • Revenue
  • HUT $138,543,000.00
  • ZLAB $427,799,000.00
  • Revenue This Year
  • HUT $74.79
  • ZLAB $41.60
  • Revenue Next Year
  • HUT $116.78
  • ZLAB $53.42
  • P/E Ratio
  • HUT $30.09
  • ZLAB N/A
  • Revenue Growth
  • HUT N/A
  • ZLAB 32.56
  • 52 Week Low
  • HUT $10.04
  • ZLAB $23.70
  • 52 Week High
  • HUT $45.25
  • ZLAB $44.34
  • Technical
  • Relative Strength Index (RSI)
  • HUT 72.90
  • ZLAB 51.53
  • Support Level
  • HUT $38.89
  • ZLAB $32.87
  • Resistance Level
  • HUT $35.52
  • ZLAB $34.72
  • Average True Range (ATR)
  • HUT 2.63
  • ZLAB 0.88
  • MACD
  • HUT 0.35
  • ZLAB 0.17
  • Stochastic Oscillator
  • HUT 91.68
  • ZLAB 62.13

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: